Explore All Access
Check if your research matches the topics covered in Drugs in Context?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Drugs in Context : Impact Factor & More
eISSN: 1740-4398pISSN: 1745-1981
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Drugs in Context Key Metrics
CiteScore 
8.1
SNIP
1.92
Topics Covered on Drugs in Context
Clinical trial
Psoriasis
Vaginal atrophy
Postmenopausal women
Ribavirin
Treatment options
Breast cancer
Rheumatoid arthritis
Type 2 diabetes
Ulcerative colitis
Type 2 Diabetes Mellitus
Ketamine
Janus kinase inhibitor
Heart failure
Atopic dermatitis
Response analysis
Sofosbuvir
Sore throat
Immunotherapy
Psoriatic arthritis
Drugs in Context Journal Specifications
| Overview | |
| Publisher | BioExcel Publishing Ltd |
| Language | English |
| Article Processing Charges | GBP 1550 |
| Publication Time | 9 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC-ND |
| OA statement | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in Drugs in Context ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Drugs in Context
Three once-weekly intra-articular injections of Hylan G-F 20 significantly improve pain relief compared with placebo in patients with chronic idiopathic knee osteoarthritis: a single-centre, evaluator-blinded and patient-blinded, randomized controlled trial.
- 5 Apr 2024
- Drugs in context
Corrigendum: Vulnerable period in heart failure: a window of opportunity for the optimization of treatment - a statement by Mexican experts.
- 26 Mar 2024
- Drugs in context
Tildrakizumab for the treatment of moderate-to-severe psoriasis: a 52-week, real-world Portuguese multicentric study.
- 18 Mar 2024
- Drugs in context
Prevention of post-contrast kidney injury in patients with cancer.
- 14 Mar 2024
- Drugs in context
Autoimmune findings in patients with silicosis in Spain.
- 26 Feb 2024
- Drugs in context
Effect of nabiximols oromucosal spray (Sativex®) on symptoms associated with multiple sclerosis-related spasticity: a case series.
- 14 Feb 2024
- Drugs in context
Three once-weekly intra-articular injections of Hylan G-F 20 significantly improve pain relief compared with placebo in patients with chronic idiopathic knee osteoarthritis: a single-centre, evaluator-blinded and patient-blinded, randomized controlled trial.
- 5 Apr 2024
- Drugs in context
Corrigendum: Vulnerable period in heart failure: a window of opportunity for the optimization of treatment - a statement by Mexican experts.
- 26 Mar 2024
- Drugs in context
Tildrakizumab for the treatment of moderate-to-severe psoriasis: a 52-week, real-world Portuguese multicentric study.
- 18 Mar 2024
- Drugs in context
Prevention of post-contrast kidney injury in patients with cancer.
- 14 Mar 2024
- Drugs in context
Autoimmune findings in patients with silicosis in Spain.
- 26 Feb 2024
- Drugs in context
Effect of nabiximols oromucosal spray (Sativex®) on symptoms associated with multiple sclerosis-related spasticity: a case series.
- 14 Feb 2024
- Drugs in context
Compare Similar Journals with Drugs in Context
Select Journals to Compare with Drugs in Context
Total journals - 7
You can select up to 3 Journals at a time
Journal of Clinical Medicine
Publisher: MDPI
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Medicine
Publisher: Elsevier
BMJ Open
Publisher: BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases
Publisher: BMJ PUBLISHING GROUP
Frontiers in Immunology
Publisher: FRONTIERS MEDIA SA
Journal of the American Academy of Dermatology
Publisher: MOSBY-ELSEVIER
0 Journals Selected to compare with
Drugs in Context
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Drugs in Context
How many articles did Drugs in Context publish last year? 
In 2023, Drugs in Context publsihed 64 articles.
What is the eISSN & pISSN for Drugs in Context?
For Drugs in Context, eISSN is 1740-4398 and pISSN is 1745-1981.
What is Citescore for Drugs in Context?
Citescore for Drugs in Context is 8.1.
What is SNIP score for Drugs in Context?
SNIP score for Drugs in Context is 1.92.
Who is the publisher of Drugs in Context?
BioExcel Publishing Ltd is the publisher of Drugs in Context.
